secwatch.observer — SEC 8-K summary
======================================

Issuer:     PAVmed Inc. (PAVM)
CIK:        0001624326
Form:       8-K
Filed at:   2025-01-21T23:59:59+00:00
Accession:  0001493152-25-003053
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 3.01, 3.02, 3.03, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PAVmed exchanges $22.35M of convertible notes for Series C preferred; targets Nasdaq compliance
--------------------------------------------------------------------------------

- Exchanged $22,347,543 in principal plus interest of Senior Secured Convertible Notes for 22,347 Series C Preferred shares.
- Remaining outstanding principal on Convertible Notes is approximately $6.6 million.
- Potential dilution: at voluntary conversion price $1.068/share, ~20.9M common shares; at floor $0.2136, ~104.6M shares.
- Company executed exchange to bolster stockholders' equity to meet Nasdaq minimum of $2.5M; compliance deadline Jan 31, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1624326/000149315225003053/0001493152-25-003053-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1624326/000149315225003053/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-003053

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer